Ok Biotech Co Ltd Total Liabilities
Ok Biotech Co Ltd total liabilities. Based on the latest financial reports, Ok Biotech Co Ltd (4155) has total liabilities worth NT$1.42 Billion TWD (≈ $44.72 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Ok Biotech Co Ltd (4155) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Ok Biotech Co Ltd (2009–2025)
Total liabilities of Ok Biotech Co Ltd from 2009 to 2025. This chart illustrates how Ok Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Ok Biotech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Ok Biotech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bound and Beyond PCL
BK:BEYOND
|
Thailand | ฿6.57 Billion |
|
Blink Charging Co
NASDAQ:BLNK
|
USA | $82.96 Million |
|
Nickel 28 Capital Corp
V:NKL
|
Canada | CA$47.43 Million |
|
Haulotte Group SA
PA:PIG
|
France | €404.55 Million |
|
TAFI Industries Bhd
KLSE:7211
|
Malaysia | RM256.67 Million |
|
Marmota Ltd
AU:MEU
|
Australia | AU$789.88K |
|
EKOS
IS:EKOS
|
Turkey | TL1.10 Billion |
|
NeueHealth Inc
NYSE:NEUE
|
USA | $1.14 Billion |
Liability Composition Analysis (2009–2025)
This chart breaks down Ok Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Ok Biotech Co Ltd.
Liquidity & Leverage Metrics
Ok Biotech Co Ltd Total Liabilities Ratios Explained
Ok Biotech Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ok Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ok Biotech Co Ltd (2009–2025)
The table below shows the annual total liabilities of Ok Biotech Co Ltd from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.27 Billion ≈ $40.12 Million |
+12.84% |
| 2024-12-31 | NT$1.13 Billion ≈ $35.55 Million |
+67.85% |
| 2023-12-31 | NT$672.26 Million ≈ $21.18 Million |
-44.66% |
| 2022-12-31 | NT$1.21 Billion ≈ $38.27 Million |
+9.47% |
| 2021-12-31 | NT$1.11 Billion ≈ $34.96 Million |
+39.43% |
| 2020-12-31 | NT$795.91 Million ≈ $25.08 Million |
-13.34% |
| 2019-12-31 | NT$918.40 Million ≈ $28.93 Million |
+57.60% |
| 2018-12-31 | NT$582.73 Million ≈ $18.36 Million |
-14.06% |
| 2017-12-31 | NT$678.07 Million ≈ $21.36 Million |
+23.14% |
| 2016-12-31 | NT$550.64 Million ≈ $17.35 Million |
+11.16% |
| 2015-12-31 | NT$495.36 Million ≈ $15.61 Million |
-11.72% |
| 2014-12-31 | NT$561.11 Million ≈ $17.68 Million |
-33.75% |
| 2013-12-31 | NT$847.00 Million ≈ $26.69 Million |
+160.10% |
| 2012-12-31 | NT$325.65 Million ≈ $10.26 Million |
+77.65% |
| 2011-12-31 | NT$183.31 Million ≈ $5.78 Million |
+93.76% |
| 2010-12-31 | NT$94.60 Million ≈ $2.98 Million |
+13.41% |
| 2009-12-31 | NT$83.42 Million ≈ $2.63 Million |
-- |
About Ok Biotech Co Ltd
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-f… Read more